Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 4,287,000 | 4,069,000 | 4,163,000 | 4,041,000 | 4,258,000 |
| Cost of Goods | 952,000 | 1,097,000 | 1,013,000 | 847,000 | 966,000 |
| Gross Profit | 3,335,000 | 2,972,000 | 3,150,000 | 3,194,000 | 3,292,000 |
| Operating Expenses | 3,745,000 | 1,985,000 | 3,098,000 | 1,746,000 | 3,352,000 |
| Operating Income | -410,000 | 987,000 | 52,000 | 1,448,000 | -60,000 |
| Pre-tax Income | -410,000 | 987,000 | 52,000 | 1,448,000 | -60,000 |
| Income Tax | -222,000 | 257,000 | 162,000 | 249,000 | -87,000 |
| Net Income Continuous | -188,000 | 730,000 | -110,000 | 1,199,000 | 27,000 |
| Minority Interests | 9,000 | 24,000 | 20,000 | 13,000 | 14,000 |
| Net Income | $-197,000 | $706,000 | $-130,000 | $1,186,000 | $13,000 |
| EPS Basic Total Ops | -0.11 | 0.42 | -0.08 | 0.71 | 0.01 |
| EPS Basic Continuous Ops | -0.11 | 0.44 | -0.07 | 0.72 | 0.01 |
| EPS Diluted Total Ops | -0.12 | 0.42 | -0.08 | 0.71 | 0.01 |
| EPS Diluted Continuous Ops | -0.11 | 0.44 | -0.07 | 0.72 | 0.01 |
| EBITDA(a) | $-334,000 | $1,092,000 | $143,000 | $1,552,000 | $43,000 |